Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 80.26 -5.48 (6.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.74 | 52 Week High | $96.38 | |||
| Open | $83.75 | 52 Week Low | $47.92 | |||
| Day High | $86.17 | P/E | N/A | |||
| Day Low | $79.92 | EPS | $-0.42 | |||
| Volume | 8,018,565 | |||||
